Foreign insurance companies often look at Japan through a product lens.
Is the product competitive?
Is there demand?
Can a partner distribute it?
Those questions still matter. But they are no longer enough.
On August 28, 2026, Japan’s Financial Services Agency published the results of public comments and related amendments for the 2025 Insurance Business Act reform package, including partial revisions to the supervisory guidelines for insurance companies and financial-service intermediaries.
The FSA says the revisions respond to earlier policy work on structural issues and competition in the non-life insurance sector. The specific reform focus is important: ensuring appropriate comparison and recommendation sales by multiple-agency insurance agents.
For foreign insurers, reinsurers, brokers, insurtechs, embedded-insurance platforms, banks, fintechs, and companies that want to distribute insurance through Japanese partners, this is a market-entry signal.
Japan is not only asking whether insurance can be sold.
It is asking how the sales recommendation is formed, explained, governed, and supervised.
The Signal Is In The Sales Channel
Insurance regulation often looks technical from the outside.
But the commercial signal here is straightforward.
Japan is paying closer attention to the place where product, customer, intermediary, incentive, and explanation meet.
That place is the sales channel.
Multiple-agency insurance agents can compare and recommend products from more than one insurer. That structure can be useful for customers, but it also creates practical conduct questions:
- How is the comparison made?
- Why is one product recommended over another?
- Are customer needs recorded clearly?
- Are incentives influencing the recommendation?
- Does the customer understand the basis for the recommendation?
- Can the insurer supervise the channel properly?
- Can the intermediary explain its process if challenged later?
For a foreign company, those are not abstract compliance questions.
They shape partnership strategy.
If a foreign insurer enters Japan through an agency, platform, broker, bank, affinity partner, or embedded-insurance arrangement, the sales model has to be designed for Japanese conduct expectations from the beginning.
Why Public Comments Matter
The FSA says it received 759 comments from 133 individuals and organizations on the relevant draft amendments and guidelines.
That volume matters because it suggests the market did not treat the revisions as a narrow paperwork change.
The FSA also says the public-comment result gives as concrete a view as possible on the regulator’s thinking around practical points for appropriate comparison and recommendation sales.
That makes the document commercially useful.
Foreign companies should not read it only as a legal update.
They should read it as a map of where Japanese implementation questions are likely to appear.
For example, if a foreign insurtech platform wants to help Japanese agents compare policies, the product design question is not only whether the interface is good.
It is whether the comparison logic, recommendation basis, recordkeeping, disclosure, audit trail, and partner responsibilities can support the way Japanese supervisors expect the channel to behave.
If a foreign insurer wants a Japanese partner to distribute a product, the question is not only whether the partner has reach.
It is whether the partner’s sales process can explain why that product is suitable for the customer when other products may also be available.
The 2028 Date Is Not A Reason To Wait
The FSA states that the amended Cabinet Office Orders will be promulgated on August 28, 2026 and come into force on March 1, 2028. The amended supervisory guidelines will also apply from March 1, 2028.
That may sound distant.
But for market-entry planning, it is close.
Insurance distribution models are not built in a few weeks. Partner selection, product localization, sales scripts, comparison materials, system changes, compliance review, training, recordkeeping, and supervisory reporting all take time.
The FSA also says multiple-agency insurance agents should consider and implement business revisions toward appropriate comparison and recommendation sales, taking into account the public-comment results and guidance from insurance companies.
The practical reading is simple:
Do not wait until 2028 to discover that the sales channel cannot support the product.
What Foreign Companies Should Review
Foreign companies considering Japan should review at least five areas.
First, the distribution route.
Will the product be sold directly, through an agent, through a broker, through a financial-service intermediary, through a bank, or inside a platform journey?
Each route changes the conduct design.
Second, the recommendation logic.
If the customer sees several products, how does the channel decide what to recommend?
If the customer sees only one product, why is that product being presented in that context?
If the product is bundled with another service, how is the customer’s intention confirmed?
Third, the explanation record.
Japan market entry often fails in the gap between a clean headquarters deck and the reality of field sales.
Companies should ask whether customer needs, comparison criteria, recommendation reasons, and disclosures are recorded in a way that can survive supervisory review.
Fourth, the incentive structure.
If commissions, volume targets, partner economics, platform placement, or internal campaigns influence what customers see, the company needs a defensible explanation of how customer interests are protected.
Fifth, the partner-control model.
The foreign company may not employ the person making the recommendation, but its Japanese market reputation can still be shaped by that sales conduct.
That makes partner due diligence and ongoing monitoring part of market entry, not an afterthought.
Embedded Insurance Has A Special Exposure
This reform signal is especially relevant to embedded insurance.
Embedded insurance works by placing insurance inside a non-insurance customer journey: travel booking, e-commerce, mobility, property rental, device purchase, financial services, or subscription products.
That model can be powerful because it reaches the customer at the moment of need.
But it can also compress explanation, comparison, and consent into a small screen and a short decision window.
In Japan, that compression needs careful design.
The commercial promise of embedded insurance is convenience.
The regulatory challenge is making convenience compatible with clear recommendation and customer-interest handling.
Foreign embedded-insurance platforms should therefore treat Japan localization as more than translation.
They need to localize the sales journey, not just the wording.
The Strategic Reading
Japan’s insurance market is not becoming closed.
It is becoming more demanding about how products reach customers.
That is a different kind of barrier.
It does not necessarily block foreign insurers, insurtechs, brokers, or platform companies. But it does raise the standard for channel design, documentation, training, partner governance, and supervisory readiness.
The companies best positioned for Japan will not only have a product that fits the market.
They will have a distribution model that can explain itself.
They will know why a customer saw a product.
They will know why a recommendation was made.
They will know how the sales channel is supervised.
They will know how to prove it later.
That is the market-entry signal.
Japan’s insurance sales reform is turning distribution into a design test.
For foreign companies, the preparation question is no longer only:
“Can we sell this in Japan?”
It is:
“Can our Japanese sales channel show why it sold this, to this customer, in this way?”
Relevant to your business?
Need deeper Japan-specific work on this?
Scope a bespoke Regulatory Risk Assessment engagement around your objective, constraints and decision deadline.
Regulatory Risk Assessment · Quote
Need ongoing coverage? Japan Market Entry Research · Quote →
Need help interpreting similar signals?
Japan Watchdesk helps overseas teams understand what Japanese-language developments actually mean for commercial decision-making.
Have you encountered something similar?
Share your experience, perspective, or question. Constructive discussion is always welcome.